Life Sciences

Opko & Entera Enter Partnership to Develop Obesity Pill

Opko Health and Entera Bio have formally announced their collaboration as the bi...

Taiho spends $400 million with a Swiss partner to “turb...

Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Ara...

Sarepta’s Elevidys Under Scrutiny Following Fatal Liver...

A young patient diagnosed with Duchenne muscular dystrophy has passed away follo...

GSK Provides Insight Into Potential HIV Treatment Data

GSK’s ViiV Healthcare has disclosed clinical data about three prospective long-a...

Hologen AI Commits Up to $430 Million to Advance MeiraG...

Hologen AI has pledged up to $430 million through a strategic partnership to sup...

Mallinckrodt & Endo Engage in $6.7B Merger

After almost a decade of contending with bankruptcy filings and opioid settlemen...

Roche Expands Obesity Pipeline with $1.65 Billion Zeala...

Roche has committed to an initial payment of $1.65 billion to enhance its growin...

J&J Halts Phase 3 Depression Program Over Efficacy Conc...

Johnson & Johnson has contributed to the ongoing issues surrounding opioids. Mon...

Daiichi Sankyo and Nosis Biosciences Collaborate to Adv...

Daiichi Sankyo has taken a step forward in expanding its interest in RNA-based t...

Pfizer and Arvinas disclose mixed breast cancer surviva...

Pfizer and Arvinas reported that their estrogen receptor degrader failed to meet...

Merck Increases Vaccine Production With New $1B Manufac...

Merck has inaugurated a fresh $1 billion, 225,000-square-foot manufacturing site...

Élancé Therapeutics Joins the Race to Develop Next-Gene...

China-based Harbour BioMed has recently announced the establishment of a new bio...

Merck develops $1B Gardasil production plant in North C...

The Durham complex of Merck now operates a new $1 billion, massive 225,000-squar...

Merck KGaA Continues Enpatoran Development Despite Phas...

Merck KGaA has faced a challenge in the clinical evaluation of its investigation...

Amgen and CytomX remove disguised T-cell engager and ax...

The phase 1 T-cell engager developed by Amgen and CytomX Therapeutics was termin...

Glenmark Issues Recall of Almost 1.5M Bottles of Generi...

The drug company Glenmark Pharma, which is located in India and has been the sub...